Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Avigan

Showing results (11-20 of 114) with videos related to

Pageof 12
Sort By:
Expert Review of Vaccines|September 23, 2006
Can leukemia-derived dendritic cells generate antileukemia immunity?Jacalyn Rosenblatt, David Avigan
Immunotherapy|November 15, 2012
Evolution of cellular immunotherapy: from allogeneic transplant to dendritic cell vaccination as treatment for multiple myelomaJon Arnason, David Avigan
Blood|December 7, 2016
Targeting the PD-1/PD-L1 axis in multiple myeloma: a dream or a reality?Jacalyn Rosenblatt, David Avigan
The New England Journal of Medicine|September 4, 2014
Current treatment for multiple myelomaDavid Avigan, Jacalyn Rosenblatt
Journal of the National Comprehensive Cancer Network : JNCCN|November 11, 2015
Role of Immune Therapies for MyelomaJacalyn Rosenblatt, David Avigan
Expert Opinion on Biological Therapy|May 26, 2016
Challenges in vaccine therapy in hematological malignancies and strategies to overcome themMyrna R Nahas, David Avigan
Expert Review of Hematology|June 2, 2018
Cellular immunotherapy as a therapeutic approach in multiple myelomaJessica Liegel, David Avigan, Jacalyn Rosenblatt
Seminars in Oncology|May 19, 2012
Dendritic/tumor fusion cells as cancer vaccinesDavid Avigan, Jacalyn Rosenblatt, Donald Kufe
Leukemia & Lymphoma|June 28, 2016
MUC1 in hematological malignanciesDina Stroopinsky, Donald Kufe, David Avigan
Expert Opinion on Biological Therapy|June 7, 2005
Dendritic cell fusion vaccines for cancer immunotherapyJacalyn Rosenblatt, Donald Kufe, David Avigan
Pageof 12

Showing results (11-20 of 114) with videos related to

Sort By:
Pageof 12
Expert Review of Vaccines|September 23, 2006
Can leukemia-derived dendritic cells generate antileukemia immunity?Jacalyn Rosenblatt, David Avigan
Immunotherapy|November 15, 2012
Evolution of cellular immunotherapy: from allogeneic transplant to dendritic cell vaccination as treatment for multiple myelomaJon Arnason, David Avigan
Blood|December 7, 2016
Targeting the PD-1/PD-L1 axis in multiple myeloma: a dream or a reality?Jacalyn Rosenblatt, David Avigan
The New England Journal of Medicine|September 4, 2014
Current treatment for multiple myelomaDavid Avigan, Jacalyn Rosenblatt
Journal of the National Comprehensive Cancer Network : JNCCN|November 11, 2015
Role of Immune Therapies for MyelomaJacalyn Rosenblatt, David Avigan
Expert Opinion on Biological Therapy|May 26, 2016
Challenges in vaccine therapy in hematological malignancies and strategies to overcome themMyrna R Nahas, David Avigan
Expert Review of Hematology|June 2, 2018
Cellular immunotherapy as a therapeutic approach in multiple myelomaJessica Liegel, David Avigan, Jacalyn Rosenblatt
Seminars in Oncology|May 19, 2012
Dendritic/tumor fusion cells as cancer vaccinesDavid Avigan, Jacalyn Rosenblatt, Donald Kufe
Leukemia & Lymphoma|June 28, 2016
MUC1 in hematological malignanciesDina Stroopinsky, Donald Kufe, David Avigan
Expert Opinion on Biological Therapy|June 7, 2005
Dendritic cell fusion vaccines for cancer immunotherapyJacalyn Rosenblatt, Donald Kufe, David Avigan
Pageof 12